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ABSTRACT 
Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe 
spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action 
potential amplitude decreased. Injection of capsaicin before BoNT/A significantly reduced these affects 
and protected the muscle twitch tension of the Extensor digitorum longus (EDL) nerve muscle 
preparation. Acute in vitro exposure of isolated nerve muscle preparations, as well as Neuro 2a cells, to 
capsaicin prevented uptake of Alexa 647 BoNT/A. Motor nerve endings as well as Neuro 2a cells express 
the capsaicin receptor, a transient receptor potential channel of the vanilloid family (TRPV1). Capsaicin 
as well as disruption of clathrin coated pits (CCPs) reduced Neuro 2a cell uptake of BoNT/A. FM1-43 
uptake indicated that exocytosis persists for BoNT/A treated Neuro 2a cells pretreated with capsaicin. 
Pre-injection of wortmannin (WMN), a PI3Kinase inhibitor, also protected mice from the paralytic effects 
of BoNT/A. When applied alone, either WMN or capsaicin selectively reduced stimulus-evoked 
transmitter release from motor nerve endings. We hypothesize that TRPV1 activation reduces PI(4,5)P2 
level within the membrane. This prevents CCP formation and uptake of BoNT/A.  
 
INTRODUCTION 
Neurotoxins produced by Clostridium botulinum that target peripheral cholinergic nerve endings are the 
most potent biological toxins. The seven serotypes of the toxin, designated BoNT/A to G (1), selectively 
cleave the SNARE complex proteins and inhibit acetylcholine release. Inhibition of neuromuscular 
transmission leads to paralysis (2). This action involves a cascade of cellular events including toxin 
binding to specific receptors (3,4), internalization by endocytosis, and translocation of the toxin light 
chain from endosomes to cytosol in a pH dependent process. The light chain metalloendoprotease of 
serotypes A and E cleave SNAP-25. Light chains of serotypes B, D, F and G cleave synaptobrevin II. 
Serotype C light chain cleaves primarily syntaxin I, as well as SNAP-25 in some cells (5,6). 
 Vesicular release of acetylcholine from motor nerve endings is an exocytic process which adds synaptic 
vesicle (SV) membrane to the nerve terminal membrane (7-10). This process of exocytosis is associated 
with compensatory endocytosis to replenish SV membrane and to maintain nerve terminal size. SV 
membrane retrieval from the terminal membrane may utilize clathrin coated pit (CCP) mediated 
endocytosis which requires phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2, 11). Increasing data indicate 
that the interaction of PI(4,5)P2 with components of the endocytotic machinery is critical to CCP 
mediated endocytosis (12-16).  
In mammalian cells, PI(4,5)P2 results from phosphatidylinositol-4-phosphate-5-kinase (PIP5K) 
phosphorylation of phosphatidylinositol-4-phosphate PI(4)P (17,18). PI(4,5)P2 interacts with several 
proteins that regulate exo-endocytosis of SVs. For example, binding of PI(4,5)P2 to synaptotagmin at 
concentrations of Ca2+ typically found in the presynaptic terminal of a stimulated neuron modulates 
docking of SVs (19). PI(4,5)P2 also binds to rabphilin 3 (20) and controls the formation of the SNARE 
complex. Other interactions that are relevant to vesicular secretion includes PI(4,5)P2 inhibition of the 
synaptic vesicle protein casein kinase I which phosphorylates several proteins including SV2 (21). Also, 
PI(4,5)P2 is required for the ATP-dependent priming step preceding exocytosis (22-25). The role of 
PI(4,5)P2 in the endocytotic pathway is critical and equally complicated. For example, PI(4,5)P2  is 
required during  early and late stages of clathrin-mediated endocytosis  (26). Furthermore, PI(4,5)P2 
interacts with proteins of the endocytotic machinery including AP2, epsin and AP180. These interactions 
are crucial for CCP formation (12-14, 32).   Binding of PI(4,5)P2 to dynamin (27,28), which is recruited 
to the neck of the invaginating clathrin-coated vesicle, enables vesicle closure by endophilin I (29). 
Activity of synaptojanin, a PI5-phosphatase that dephosphorylates PI(4,5)P2 to PI(4)P (30), is important 
for uncoating of endocytic vesicles (31). These observations provide a compelling model of PI(4,5)P2 in 
the regulation of CCP dependent endocytosis.     
Neuronal internalization of BoNT/A involves CCP mediated endocytosis (33,34,35). That is, disruption 
of CCP by incubating cells with potassium depleted buffer followed by hypotonic shock inhibits BoNT/A 
uptake into Neuro 2a cells (35,36). Thus, it is of importance to test whether disruption of CCP by 
depletion of membrane bound PI(4,5)P2 reduces the uptake of BoNT/A. Here, we report that the mouse 
NMJ expresses the capsaicin receptor TRPV1. In vivo and in vitro activation of TRPV1 inhibited 
BoNT/A uptake into motor nerve endings. Furthermore, we report that wortmannin (WMN) inhibits the 
effects of BoNT/A in vivo. Our data suggest that capsaicin inhibits BoNT/A uptake by depleting  
PI(4,5)P2 and disrupting CCP mediated endocytosis. The net effect is capsaicin-induced protection of the 
NMJ from the inhibitory affects of BoNT/A.  
METHODS 
Animals 
Adult Swiss Webster mice were anesthetized with ketamine (100 mg/kg) and xylazine (9 mg/kg) mixture 
(KXM) intraperitoneally. Three μl of 6.67 pM BoNT/A in HEPES Ringer Solution (HRS) was injected 
bilaterally with a 26 Gauge Hamilton syringe into the space surrounding the EDL innervation region. The 
skin incision was then surgically closed. Capsaicin was either bilaterally coinjected (3 μl of 1 mM stock 
solution) immediately before BoNT/A or preinjected at 4 or 8 hrs prior to BoNT/A. Wortmannin (3 μl of 
1 mM) was injected bilaterally 6 hrs prior to BoNT/A. All procedures were approved by the Institutional 
Animal Care and Use Committee. 
Cell culture and FM1-43 loading 
Mouse cholinergic neuroblastoma (Neuro 2a) cells were cultured in DMEM-F12 medium supplemented 
with 10% Fetal Bovine Serum and antibiotics. Briefly, cells seeded on poly-L-lysine coated coverslips 
were incubated with either 40 mM KCl HRS alone (control) or in combination with 10 pM BoNT/A for 
30 min at room temperature. Subsequently, cells were washed twice with PBS and further incubated with 
FM1-43 (1 µg/ml) in 40 mM KCl HRS for 10 min. In studies of capsaicin, cells were incubated with 10 
µM capsaicin in HEPES for 15 min prior to incubation in 10 pM BoNT/A plus 40 mM KCl. Cells were 
washed twice with HRS pH 7.4 and observed with a Zeiss (Oberkochen, Germany) LSM-510 confocal 
microscope equipped with an argon laser (488 nm). Images were analyzed with the ImageJ software. 
Disruption of CCP 
CCPs were disrupted as described previously (35).  
Immunoblotting 
Cultured cells or diaphragm muscles dissected from anesthetized mice were flash frozen in liquid nitrogen 
and homogenized in phosphate buffered saline (PBS) containing 1% NP-40 and complete protease 
inhibitor cocktail (Amersham, USA). After centrifuging the homogenate in the cold at 14,000 rpm for 10 
min, the lysate (40 µg) was resolved via SDS-PAGE after boiling in 1X Laemmli buffer. Immunoblotting 
was performed with anti-TRPV1 antibody (Santa Cruz Biotechnology, Inc., USA).  
Immunohistochemistry 
Preparations were fixed with 4% paraformaldehyde, permeabilized with 1% Triton, blocked with 2% 
BSA, incubated with TRPV1 antibody in PBS (1:200) followed by FITC labeled secondary antibody 
(1:5000), washed with PBS, mounted with vectashield on a glass slide and imaged. All treatments after 
fixing were performed at 4 ºC. 
Two electrode voltage clamping 
Triangularis sterni nerve-muscle preparations (TS; 37) were dissected from isoflurane anesthetized adult 
Swiss Webster mice and superfused in HRS (22-25 °C) containing (mM): NaCl (135),  KCl (5), MgCl2 
(1), CaCl2 (2), Na2HPO4 (1), HEPES (10, pH 7.4), glucose (5.5). To activate transmitter release, the TS 
nerve was drawn into a suction electrode and stimulated supramaximally. Spontaneous and stimulus 
evoked transmitter release were recorded by two electrode voltage clamping (Axoclamp 2B, Molecular 
Devices Inc., USA). For controls, the HRS contained 0.75 to 4 µM μ Conotoxin GIIIB to prevent 
mechanical responses to nerve stimulation. Control recordings were made before application of 100 M 
capsaicin or 100 M wortmannin. Collected data were analyzed with pCLAMP 9.0 software.  
Muscle twitch tension 
EDL nerve-muscle preparations were dissected and mounted in a glass chamber (Rodnoti Glass 
Technology, Inc., USA) filled with oxygenated (95% O2 - 5% CO2) normal Ringer solution (pH 7.4, 37 
°C) containing (mM) NaCl (135), KCl (5), MgCl2 (1),  CaCl2 (2), Na2HPO4 (1), NaHCO3 (15), glucose 
(5.5). The EDL nerve was drawn into a suction electrode for indirect activation of muscle twitches. One 
tendon of the muscle was tied to a Grass Force transducer connected to a Digidata 1440A (Molecular 
Devices, USA) for acquisition of the mechanical response to nerve stimulation. Muscles were stretched to 
optimal length for force generation and equilibrated for 15 min prior to stimulation at 0.1 Hz for data 
acquisition. Collected data were analyzed with pCLAMP 9.0 software. 
Confocal microscopy 
TS nerve-muscle preparations were bathed in 667 pM Alexa 647 labeled BoNT/A. Nerve stimulation (1 
Hz) or addition of 40 mM KCl (NaCl reduced to 100 mM to maintain osmolarity) to the BoNT/A-
containing HRS initiated toxin uptake. After 90 min, preparations were fixed and exposed to Alexa 488 α-
Bungarotoxin (α-BTX; 1 ng/ml, 6 hrs at 4°C) to label endplate acetylcholine receptors. The endplate 
region of the muscle was cut out, mounted on a slide with vectashield and observed with a NIKON LSM-
410 confocal microscope equipped with argon and HeNe lasers at the Confocal Imaging Facility of the 
New Jersey Medical School.  
Muscle strength assessment 
Mice were adapted for 1 week to 300 sec episodes on a rotating (15 rpm) rod (Rotamex-5, Columbus 
Instruments, Inc., USA) prior to study. To evaluate motor strength and coordination after BoNT/A 
injected alone or in combination with capsaicin, duration on the rotarod was tested biweekly. Mean 
duration on the rotarod was averaged for 3 runs 30 min apart. The in vivo muscle strength of legs and 
waist was assessed and scored using criteria of table 1.  
Electromyography (EMG) 
Animals anesthetized with KXM intraperitoneally were taped prone to a polystyrene foam board. A 
heated water pad maintained body temperature between 32 and 38° C. Stimulating electrodes (0.7 mm 
needles) were insulated with polytef (Dantec sensory needle, Skorlunde, Denmark); cathode was placed 
close to the sciatic nerve and the anode was placed subcutaneously 1 cm proximally. Motor responses 
were recorded with a ring electrode placed distal to the site of BoNT/A injection. The reference ring 
electrode was placed 1.2 cm distal to the recording electrode. Ground electrode was placed in the contra-
lateral limb. Stimuli delivered through a stimulator were recorded by Dantec amplifiers connected to a 
computer. Filter settings were 500 Hz/5KHz. Stimulus intensity was increased until the compound muscle 
action potential (CMAP) was maximized. CMAP amplitude was recorded for both hind limbs.  
Chemicals and drugs 
BoNT/A and Alexa 647 BoNT/A were from Metabiologics Inc (WI, USA) and BB Tech (MA, USA), 
respectively. Wortmannin was from Calbiochem, USA. Other chemicals and drugs were from Sigma 
(USA).  
Data analyses 
Data were expressed as mean ± S.E.M. Student's t test evaluated the statistical significance for differences 
of population means; ** and *** indicate p < 0.001 and < 0.0001, respectively. 
RESULTS 
The right hind limb of the mouse in Figure 1 A was injected with capsaicin 4 hrs prior to bilateral 
injection of BoNT/A. Within 24 hrs, the toe spread reflex (TSR) was abolished in the left limb. In 
contrast, TSR remained normal for the capsaicin pre-injected limb. Figure 1 A summarizes data from 24 
mice injected with BoNT/A either immediately or at 4 or 8 hrs after capsaicin injection into the same hind 
limb.  While BoNT/A abolished the TSR for all control mice (n=16), TSR was not altered for all 
capsaicin pre-treated mice. To further test in vivo muscle function and coordination after BoNT/A, mice 
were challenged with a rotating rod. All non-treated mice walked on the rod for at least 300 sec. Walk 
time significantly declined at 24 hrs and reached a minimal value of 127±48 sec at 4 days after BoNT/A. 
Walk time recovered to 300 sec at 20 days after BoNT/A alone.  In contrast, walk time did not decline 
when BoNT/A was injected at 4 hrs after capsaicin (Figure 1 B).  Furthermore, scoring for motor strength, 
by a blinded investigator using the criteria of table 1, suggested that capsaicin protected against the 
weakness caused by BoNT/A. That is, motor strength score was significantly less than control at 2 and 3 
weeks after BoNT/A alone. In contrast, capsaicin pre-injected mice retained a normal score (Figure 1 C). 
Protection of muscle function may explain the larger weight of capsaicin pretreated versus BoNT/A alone 
treated mice (Figure 1 D). 
The preceding effects of capsaicin were associated with partial protection of neuromuscular 
physiology in vivo. Although CMAP amplitude declined for BoNT/A alone as well as BoNT/A after 
capsaicin groups of mice, the magnitude of the decline was significantly less for the latter group. That is, 
CMAP amplitude was 11.3 ± 2.3 (n=4), 0.7 ± 0.28 (n=4) and 4.6 ± 0.92 (n=4) mV at 4 weeks after 
BoNT/A for control, BoNT/A alone and capsaicin pre-injected mice, respectively.  At 8 weeks after 
BoNT/A, CMAP amplitude had partially recovered for the BoNT/A alone and capsaicin pre-injected 
groups to 2.6 ± 0.79 (n=4) and 6.7 ± 1.24 (n=4) mV, respectively. For both groups of mice, CMAP 
amplitude remained abnormally low as late as 14 weeks after BoNT/A (Figure 2 B). Capsaicin alone had 
no affect on muscle strength or CMAP amplitude (Figure 2 C).  
The force generating capacity was tested for EDL preparations isolated from mice injected with 
BoNT/A alone or after capsaicin. As anticipated, the nerve-evoked muscle twitch tension was reduced at 
24 hrs after BoNT/A alone. However, pre-injection of capsaicin significantly reduced this affect of 
BoNT/A (Figure 3 A); tension was 140 ± 60.0 (n=4) and 500 ± 100 (n=4) mg for mice injected with 
BoNT/A alone and at 4 hrs after capsaicin, respectively. Thus, while BoNT/A continued to significantly 
reduce twitch tension after capsaicin, the reduction was significantly less than after BoNT/A alone 
(Figure 3 B). Capsaicin injected alone had no effect on force generation (Figure 3 C). 
Since capsaicin is an agonist of the TRPV1 receptor, we assayed whole muscle for this protein. 
Immunoblots (Figure 4 A) revealed TRPV1 in NMJ as well as Neuro 2a cells. The TRPV1 antibody also 
detected this protein on motor nerve endings and Neuro 2a cells (Figure 4 B and C). 
The protective role of TRPV1 was observed for Neuro 2a cells induced to take up FM1-43, a 
fluorescent marker of exocytosis (Figure 5 A). That is, exposure to BoNT/A prevented 40 mM KCl-
induced uptake of FM1-43. This inhibitory effect of BoNT/A was not observed for Neuro 2a cells 
exposed to capsaicin prior to BoNT/A (Figure 5 B).   
Capsaicin pretreatment reduced BoNT/A uptake. Figure 6 presents representative images of 
NMJs in the TS muscle labeled with Alexa 488 BTX and Alexa 647 BoNT/A; neurotoxin uptake was 
activated by nerve stimulation (A) or depolarization with 40 mM  KCl (B). Comparison of the upper and 
lower panels of Figure 6 A and B indicates that pre-exposure to 100 µM capsaicin reduced BoNT/A 
uptake. Similarly, capsaicin reduced 40 mM KCl stimulated Alexa 647 BoNT/A uptake into Neuro 2a 
cells. As expected (34,35), CCP disruption  also reduced BoNT/A uptake into Neuro 2a cells (Figure 7).  
Growth and nucleation of CCPs involves PI(4,5)P2 (32). PI(4,5)P2 depletion will affect the 
formation of CCP. To test this hypothesis, we examined the effect of WMN which inhibits 
phosphatidylinositol 3-kinase (PI3K) as well as PI5K to prevent PI(4,5)P2 synthesis. The right hind limb 
of the mouse in Figure 8 A was injected with 3 µl of 1 mM WMN solution 6 hrs prior to bilateral 
injection of BoNT/A. Within 24 hrs, the TSR was abolished in the left limb. In contrast, TSR remained 
normal for the WMN pre-injected limb. This protective action of WMN was observed for all four mice 
pretreated with WMN. Thus, WMN is similar to capsaicin in protecting neuromuscular function against 
BoNT/A. 
Acute in vitro application of 100 M WMN alone decreased the amplitude of endplate currents 
(EPCs) but not spontaneous miniature EPCs (Figure 8 B-E). Since the frequency of miniature EPCs (F) 
was unaltered, these data suggest that WMN reduces the quantal content of EPCs. The inhibitory action of 
WMN did not reverse with wash during the 4-6 hr time frame of our in vitro electrophysiological study. 
Similarly to WMN, 2 hrs of acute in vitro application of 100 M capsaicin reduced the amplitude 
of EPCs (Figure 9). Capsaicin changed neither the amplitude (2.2 ± 0.18 nA before and 2.5 ± 0.25 nA 
after capsaicin) nor the frequency (1.8 ± 0.2 sec-1 before and 1.6 ± 0.1 sec-1 after capsaicin) of miniature 
EPCs. In contrast, capsaicin reduced the quantal content of EPCs from 38 ± 1.2 to 8 ± 0.5. 
DISCUSSION 
Mechanism of capsaicin protection against BoNT/A 
This study shows that pretreatment with capsaicin protected the mouse NMJ from the paralytic effects of 
BoNT/A. Our observations, when considered in light of current understanding of BoNT/A uptake, 
suggest the schematic of supplementary figure 1 to explain the protective action of capsaicin. According 
to this model, TRPV1 channels on cholinergic nerves mediate the action of capsaicin. We demonstrate 
that TRPV1 is expressed in motor nerve terminals and in Neuro 2a cells by western blotting and 
immunocytochemistry.  Mammalian homologues of Drosophila transient receptor potential (TRP) 
channels are plasma membrane cation permeable channels that interact with a variety of intracellular 
proteins and macromolecular complexes (38). Thus, capsaicin protection against BoNT/A may involve 
ion flux and/or modulation of intracellular signaling cascades.    
Capsaicin reduced Alexa 647 BoNT/A labeling of motor nerve endings as well as Neuro 2a cells. 
Disruption of CCPs mimicked the later effect of capsaicin. The model of supplementary figure 1 suggests 
that PI(4,5)P2 regulates CCP-mediated BoNT/A endocytosis by depleting PI(4,5)P2 which disrupts CCP-
mediated BoNT/A uptake. A growing literature addresses the role of phosphoinositides in the regulation 
of TRP channels. For example, membrane bound PI(4,5)P2 regulates TRPV1 (40,41). PI(4,5)P2 also 
affects the nucleation and growth of CCPs (32). Hence, it is reasonable to hypothesize that Ca2+ flowing 
into the nerve terminal through capsaicin-activated TRPV1 channels activates phospholipase C which 
hydrolyzes PI(4,5)P2. The resultant disruption of CCPs reduces endocytosis of BoNT/A.  
The upper row of supplementary figure 1 depicts synaptic vesicles (SVs) which have fused with the motor 
nerve terminal membrane during exocytosis. In the absence of capsaicin pretreatment, fused SV 
membranes are coated with nucleated clathrin filaments (hexagons of red circles) in a PI(4,5)P2 dependent 
manner. BoNT/A can bind to gangliosides and SV2 available on the exocytosed SV. When endocytosed 
via the CCP mediated process BoNT/A is ready for translocation into the nerve terminal cytosol. The 
second row of the right panel introduces capsaicin which activates TRPV1 protein on the motor nerve 
teriminal. Ca2+ influx via TRPV1 activates phospholipase C which hydrolyzes PI(4,5)P2. The reduction of 
membrane PI(4,5)P2 disrupts clatrin coating of the SV. As a consequence, less BoNT/A is endocytosed.  
 
The protective effect of capsaicin on muscle performance in vivo (Figure 1) was associated with partial 
protection of the compound action potential (Figure 2) as well as the force of the nerve initiated twitches 
(Figure 3) for muscles nearby the site of BoNT/A injection. TRPV1, the capsaicin receptor, was found on 
native motor nerve endings as well as on cholinergic neuroblastoma Neuro 2a cells (Figure 4). Capsaicin 
preserved FM1-43 uptake, an indication of continued exocytosis, for Neuro 2a cells exposed to BoNT/A 
(Figure 5). Capsaicin reduced uptake of BoNT/A into motor nerve endings as well as Neuro 2a cells; 
disruption of CCPs also reduced BoNT/A uptake into Neuro 2a cells (Figures 6 and 7). Pretreatment with 
WMN, an inhibitor of PI(4,5)P2 synthesis, also protected muscle behavior from BoNT/A (Figure 8). 
When applied alone WMN and capsaicin reduced the quantal content of EPCs (Figures 8 and 9).  
Effects of capsaicin pretreatment 
In vivo skeletal muscle performance was evaluated with performance on a rotating rod, hind limb strength 
evaluation, the TSR and electromyography. When 3 l of 6.67 pM BoNT/A was injected into the 
innervation region of the EDL muscle, all of the preceding indicators of neuromuscular function declined 
within 24 hrs. Capsaicin injection 4 or 8 hrs as well as immediately before BoNT/A prevented these in 
vivo affects of BoNT/A. It is significant that electromyographic measurements in vivo and muscle 
mechanics in vitro showed no effect of capsaicin alone. This is discussed below in relation to the acute, in 
vitro inhibitory action of capsaicin, as well as WMN, on the quantal content of EPCs.  
The in vivo electromyographic and in vitro mechanical measurements demonstrated that capsaicin does 
not produce 100% protection against BoNT/A. Despite the partial protection of EDL functions and 
CMAP amplitude inhibition, the capsaicin pretreated animals did not show any sign of BoNT/A induced 
paralysis. This is consistent with the observations of decreased internalization of fluorescently labeled 
BoNT/A into mouse NMJ in vitro (Figure 5). However, capsaicin did not totally inhibit BoNT/A uptake. 
Also, when the mouse NMJ was exposed to capsaicin at a concentration of 100 µM, it decreased EPC 
amplitude in 2 hours. In contrast, injection of capsaicin alone did not affect muscle function and 
performance. Thus, it appears that the in vitro tissue effects of BoNT/A which persist after capsaicin 
pretreatment are not sufficient to inhibit muscle performance. This suggests participation of in vivo 
compensatory mechanisms. 
Disruption of CCPs, a plausible mechanism for reduced BoNT/A uptake 
Recent studies (33,35) demonstrate the role of CCP in BoNT/A uptake.  When CCPs are disrupted, 
BoNT/A is less active on Neuro 2a cells. Our experiments with Neuro 2a cells reveal that disruption of 
CCPs inhibited activity independent uptake of BoNT/A (Figure 7). This reduced uptake might involve 
PI(4,5)P2 since hypotonicity transiently reduces PI(4,5)P2 level (42). Hence, we hypothesize that 
capsaicin disrupts CCPs by stimulating Ca2+ entry via TRPV1 channels. Ca2+ then activates phospholipase 
C (PLC) to hydrolyze PI(4,5)P2. Our in vivo experiment with WMN supports this hypothesis. That is, 
inhibition of PI(4,5)P2 resynthesis by blocking PI3Kinase and PI5Kinase with WMN  protects the mouse 
NMJ from the inhibitory effects of BoNT/A.  
Capsaicin protects FM1-43 labeling of synaptic vesicles 
BoNT/A (10 pM) significantly inhibited activity dependent (40 mM KCl depolarization mediated) 
labeling of the Neuro 2a secretory vesicles with FM1-43  (Figure 5). This is consistent with earlier 
observations showing that BoNT/A reduced FM1-43 labeling of nerve endings in the mouse 
hemidiaphragm (43). Pretreatment of Neuro 2a cells with capsaicin prior to BoNT/A exposure protected 
the labeling of secretory vesicles. These observations are consistent with our hypothesis that capsaicin 
pretreatment reduced uptake of BoNT/A  and preserved exocytosis-dependent labeling with FM1-43.  
 Capsaicin inhibits CCP dependent endocytosis. 
Our results suggest that chronic stimulation of motor neurons with capsaicin reduces clathrin dependent 
endocytosis of BoNT/A. In the absence of any interventions, BoNT/A is trafficked intracellularly via a 
clathrin dependent endocytotic pathway. Interruption of BoNT/A uptake follows hypo-osmotic or  
capsaicin-induced disruption of CCP formation. A similar mechanism for inhibition of clathrin dependent 
endocytosis of GABAB receptors has been suggested for sensory neurons (44).  
To date, no studies have reported a direct effect of capsaicin on motor neurons. This study reveals that 
acute in vitro capsaicin application decreases stimulus-evoked transmitter release. In contrast, a dose of 
capsaicin which protects against BoNT/A in vivo lacked any detectable affect on muscle function.  This 
discrepancy may be attributed to in vivo compensatory mechanisms that are not present in the in vitro 
experiments. Two critical factors that potentially regulate CCP formation are membrane bound PI(4,5)P2 
and extracellular K+. Depletion of PI(4,5)P2 by ionomycin or exposure of cells to K+ depleting conditions 
followed by hypotonic shock inhibit  clathrin dependent endocytosis.  
Overall, our results provide evidence for the involvement of proteins that are critical to the regulation of 
BoNT/A endocytosis. Supplementary figure 1 presents a model where capsaicin affects the BoNT/A 
uptake by interfering with clathrin . However, capsaicin may have other direct or indirect effects on 
binding of BoNT/A to its receptor complex. We suggest this is a remote possibility since recordings of 
EDL contractions indicate only partial protection from BoNT/A. Furthermore, BoNT/A endocytosis was 
not completely prevented by capsaicin. Another possibility is that capsaicin might hasten the process of 
BoNT/A clearance from the intracellular space. Our hypothesis of clathrin involvement and its regulation 
by PI(4,5)P2 is further supported by the finding that WMN (PI3K inhibitor) inhibited the effect of 
BoNT/A in vivo. WMN sensitive PI kinases are involved in clathrin-dependent endocytosis where AP2 
and dynamin serve as potential effectors (45,46). The plekstrin homology domain of dynamin binds to 
phosphoinositides (46, 26) and cleaves clathrin-coated pits from the plasma membrane (47,48). Also, 
dynamin may preferentially bind to PI(4,5)P2, a product of PI 4-kinase that is reduced at higher 
concentrations of WMN (49). WMN pretreatment prevented the paralytic effects of BoNT/A in the 
mouse. In vitro treatment of WMN alone, like capsaicin alone, also significantly decreased stimulus 
evoked transmitter release. However, this did not cause any failure of transmitter release in response to 
stimuli. This effect could be mediated by severe inhibition of PI(4,5)P2 that is essential for the normal 
maintenance of endo-exocytosis. However, such an in vitro effect was not manifested with in vivo WMN 
injection; that is, mice injected with WMN alone showed normal muscle performance. Therefore, it is 
compelling to speculate that WMN mediated inhibition of PI(4,5)P2 resynthesis could inhibit clathrin 
association and thereby reduce BoNT/A endocytosis. 
Our results support a novel mechanism for the inhibition of clathrin dependent endocytosis of BoNT/A by 
capsaicin. This hypothesis promises new understanding of pathways in BoNT/A trafficking into the motor 
nerve terminal and the involvement of important regulatory cascades of BoNT/A endocytosis. 
Figure legends 
Figure 1. Capsaicin protects mice from the paralytic effects of BoNT/A. A inset illustrates the 
protective effect of capsaicin pretreatment on the mouse TSR. The histogram summarizes TSR score with 
BoNT/A alone (n=16) or capsaicin pretreatment (n=24); capsaicin was injected immediately (n=14) or at 
4 (n=6) or 8 (n=4) hrs before BoNT/A. TSR was scored according to the number (0-5) of toes which the 
mouse could extend and flex from the midline of the foot. B shows performance of mice on the rotarod.  
Four groups of mice (control, + CAP, + BoNT/A bilaterally and + CAP + BoNT/A bilaterally; 4 mice in 
each group) were studied. BoNT/A was injected on day 8.  The time that each mouse walked on the 
rotarod was averaged for three trials at each time point and plotted against time. C summarizes motor 
strength (%) evaluated as per table 1.  
Figure 2. Capsaicin preserves muscle function in vivo. A. Illustrative records of CMAP for control (a), 
4 and 8 weeks after BoNT/A alone (b and d) or BoNT/A after pretreatment with capsaicin (c and e). B 
summarizes the effect of BoNT/A with and without capsaicin pretreatment. CMAP amplitude (%) is 
plotted against time in weeks after BoNT/A. Bars represent average of normalized values ± S.E.M. C 
summarizes the effect of capsaicin alone. Left axis represents the normalized muscle strength in (%). 
Right axis is the normalized CMAP amplitude (%) of untreated control and mice that received only 
capsaicin. 
Figure 3. Capsaicin preserves EDL contractility. A. Represents twitch tension records for control, 
BoNT/A alone and BoNT/A plus capsaicin pretreated animals. B summarizes normalized twitch tension 
for EDL exposed to BoNT/A alone or after capsaicin in vivo. Bars are mean ± S.E.M.  C summarizes 
normalized twitch tension for untreated control and capsaicin alone treated EDL. 
Figure 4. Mouse NMJ and Neuro 2a cells express TRPV1. A. Immunoblot shows TRPV1 in lysates of 
HEK293 cells transfected with TRPV1 cDNA, mouse hemidiaphragm and Neuro 2a cells. Lower panels 
illustrate TRPV1 expression in the motor nerve and Neuro 2a cells (B, C).   
Figure 5. Capsaicin pretreatement protects FM1-43 uptake. A. Images of KCl stimulated FM 1-43 
labeling of control (left), BoNT/A alone (middle) and capsaicin pretreated (right) Neuro 2a cells. B. 
Average fluorescence intensity (arbitrary units; a.u.) ± S.E.M. Numbers in bars indicate the number of 
cells summarized in the mean value. 
Figure 6. Capsaicin reduces BoNT/A uptake into motor nerve endings. A. Representative 
fluorescence labeling of endplate ACh receptors with Alexa-488 α-BTX and motor nerve endings with 
Alexa-647 BoNT/A for control (a, b) and capsaicin pretreated (c, d) preparations. BoNT/A was loaded 
with nerve stimulation. B. BoNT/A was loaded with 40 mM KCl; BoNT/A alone (e, f) or after capsaicin 
pretreatment (g, h).  
Figure 7. Capsaicin effect on BoNT/A uptake into Neuro 2a cells mimics CCP disruption. 
Fluorescence labeling with Alexa 647 BoNT/A for: A) BoNT/A alone, B) BoNT/A after capsaicin, C) 
BoNT/A after CCP disruption. BoNT/A was loaded by incubating cells with Alexa 647 BoNT/A in 40 
mM KCl. Right panels represent corresponding bright field images. 
Figure 8. Wortmannin protects mice from BoNT/A in vivo but acutely decreases quantal content of 
end plate currents in vitro. A. Inset photo shows TSR in a mouse that received bilateral injection of 
BoNT/A 24 hrs earlier. The right limb was pretreated with WMN (3 µl of 1 mM) 6 hrs prior to BoNT/A; 
TSR was protected for the WMN pretreated limb. B and C. Representative EPC and MEPC recorded 
before and 2 hrs after in vitro WMN exposure respectively. D. The mean ± S.E.M. for EPCs. E. MEPC 
amplitudes before and after WMN. F. MEPC frequency. 
Figure 9. Acute in vitro capsaicin treatment reduces quantal content of end plate currents. A and B. 
Representative traces of EPCs (A) and MEPCs (B) measured before and after 100 μM capsaicin 
application for 2 hrs. Histograms showing mean ± S.E.M. amplitudes for EPCs (C) and MEPCs (D) 
before and after capsaicin, MEPC frequency (E) before and 2 hr after capsaicin application and quantal 
content (F) before and after capsaicin.  
Supplimentary figure 1. Model of possible mechanism underlying the protective effect of capsaicin 
against BoNT/A. In the absence of capsaicin pretreatment (left panel), fused SV membranes are coated 
with nucleated clathrin filaments (red hexagons) in a PI(4,5)P2 dependent manner. BoNT/A can bind to 
gangliosides (G) and SV2 available on the CCP. Upon endocytosis via the CCP mediated process 
BoNT/A is ready for translocation into the nerve terminal cytosol. Right panel introduces capsaicin which 
activates TRPV1 protein on the motor nerve teriminal. TRPV1 inwardly conducts Ca2+ to activate 
phospholipase C which hydrolyzes PI(4,5)P2. The reduction of membrane PI(4,5)P2 disrupts clatrin 
coating of the SV. As a consequence, less BoNT/A is endocytosed.  
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